Jason A Keyes Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Jason A Keyes.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Jason A Keyes. Jason A Keyes is a EVP, Chief Financial Officer in Orexigen Therapeutics, Inc. ($OREX) and a SVP, Chief Financial Officer in Orexigen Therapeutics, Inc. ($OREX) and a Director in Sesen Bio, Inc. ($SESN) and a Chief Financial Officer in Equillium, Inc. ($EQ).
Address: 3344 NORTH TORREY PINES COURT SUITE 200 LA JOLLA 92037 CA
Companies in which Jason A Keyes is an Insider
Equillium, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Jason A Keyes: Chief Financial Officer
Holdings: 115,720 shares
Latest Transaction: May 28 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Orexigen Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Jason A Keyes: EVP, Chief Financial Officer, SVP, Chief Financial Officer
Holdings: 3,031 shares
Current Value: $13,882
Latest Transaction: Oct 17 2017
$OREX Market Capitalization: $70.30M
$OREX Previous Close: $4.58
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Sesen Bio, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Jason A Keyes: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: May 05 2021
$SESN Market Capitalization: $34.48M
$SESN Previous Close: $2.34
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Jason A Keyes
Sentiment: All, EQ, OREX, SESN
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 28 2021 | EQ | Equillium, Inc. | Keyes Jason A | Chief Financial Off ... | Sell | S | 6.50 | 5,000 | 32,484 | 115,720 | 120.7 K to 115.7 K (-4.14 %) |
| May 05 2021 | SESN | Sesen Bio, Inc. | Keyes Jason A | Director | Option Exercise | A | 2.79 | 92,500 | 258,075 | 92,500 | |
| Dec 28 2020 | EQ | Equillium, Inc. | Keyes Jason A | Chief Financial Off ... | Sell | S | 4.74 | 8,000 | 37,914 | 120,720 | 128.7 K to 120.7 K (-6.22 %) |
| May 08 2020 | SESN | Sesen Bio, Inc. | Keyes Jason A | Director | Option Exercise | A | 0.63 | 59,000 | 37,135 | 59,000 | |
| Apr 24 2020 | EQ | Equillium, Inc. | Keyes Jason A | Chief Financial Off ... | Option Exercise | A | 2.45 | 90,000 | 220,500 | 90,000 | |
| Apr 24 2020 | EQ | Equillium, Inc. | Keyes Jason A | Chief Financial Off ... | Option Exercise | D | 4.75 | 90,000 | 427,500 | 0 | |
| Apr 24 2020 | EQ | Equillium, Inc. | Keyes Jason A | Chief Financial Off ... | Option Exercise | A | 2.45 | 70,000 | 171,500 | 70,000 |